Diamond Member Pelican Press 0 Posted October 23, 2025 Diamond Member Share Posted October 23, 2025 Bengaluru: The U.S. Food and Drug Administration said on Friday it had approved Stealth Biotherapeutics’ once-daily injection for a rare, genetic disease that primarily affects males, making it the first treatment to be greenlit for the condition. Stealth’s Forzinity was granted accelerated approval for treating Barth syndrome, in patients weighing at least 30 kg. Barth syndrome is a rare… This is the hidden content, please Sign In or Sign Up This is the hidden content, please Sign In or Sign Up 0 Quote Link to comment https://hopzone.eu/forums/topic/284944-fda-grants-first-ever-approval-for-barth-syndrome-treatment-in-males-ethealthworld/ Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.